Optimized intranasal delivery of segesterone acetate progestin to the brain using nanoemulsions and microemulsions

Segesterone acetate (SA) is a selective and potent progesterone receptor agonist with potential application in the treatment of neurological diseases, such as multiple sclerosis and stroke. In this study, a microemulsion (ME) and three nanoemulsions (NEs) with a target SA concentration of 0.48 mg/g were developed for intranasal administration and extensively characterized regarding their physicochemical properties, stability, antimicrobial activity, and safety (in primary cortical cells, Hen’s Egg Test, MucilAir™ model and in rats). Plasma and brain SA levels were measured 30 and 60 min after intranasal administration in male rats.

Authors

Institutions

Publication Details

Journal
Drug Delivery and Translational Research
Published
2025-06-18
DOI
https://doi.org/10.1007/s13346-025-01897-7
Citations
1
Primary Topic
Advanced Drug Delivery Systems
Type
article
Field-Weighted Citation Impact
0.79

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Optimized intranasal delivery of segesterone acetate progestin to the brain using nanoemulsions and microemulsions

Susana Alves Ferreira, Márcio Rodrigues, Carlos Gaspar, Ana Palmeira‐de‐Oliveira et al.
1 citations
Drug Delivery and Translational Research
Advanced Drug Delivery Systems
0.79
article

Optimized intranasal delivery of segesterone acetate progestin to the brain using nanoemulsions and microemulsions

Susana Alves Ferreira, Márcio Rodrigues, Carlos Gaspar, Ana Palmeira‐de‐Oliveira, Graça Baltazar, Régine Sitruk‐Ware, Rui Caetano Oliveira, Izamara Maocha, Carina Peres, Rita Palmeira‐de‐Oliveira, Shimin Zhang, Sofia Silva, Adriana O. Santos, Sara Meirinho, Narender Kumar, Anabela Chiangalala
article en
1 citations

Abstract

Segesterone acetate (SA) is a selective and potent progesterone receptor agonist with potential application in the treatment of neurological diseases, such as multiple sclerosis and stroke. In this study, a microemulsion (ME) and three nanoemulsions (NEs) with a target SA concentration of 0.48 mg/g were developed for intranasal administration and extensively characterized regarding their physicochemical properties, stability, antimicrobial activity, and safety (in primary cortical cells, Hen’s Egg Test, MucilAir™ model and in rats). Plasma and brain SA levels were measured 30 and 60 min after intranasal administration in male rats.

Drug Delivery and Translational ResearchVol. 15(12)
University of Beira Interior (PT), Hospitais da Universidade de Coimbra (PT), Universidade Politécnica da Guarda (PT), Population Council (US), Centre for Research and Development (ZW), University of Coimbra (PT)
Universidade da Beira Interior, European Commission, Programa Operacional Regional do Centro, European Regional Development Fund
Openalex Percentile: Top 27%
Advanced Drug Delivery Systems
0.79
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.